Aprea Therapeutics, Inc. (APRE): 5 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 2, 2026 | Hamill John P. Officer | 5,700 | $0.89 | $5.1K | no history |
| Feb 2, 2026 | Gilad Oren Director, Officer | 28,100 | $0.89 | $25.0K | no history |
| Dec 11, 2025 | Hamill John P. Officer | 5,000 | $1.17 | $5.8K | no history |
| Dec 11, 2025 | Duey Marc Director | 21,459 | $1.17 | $25.1K | no history |
| Apr 4, 2025 | Gilad Oren Director, Officer | 5,500 | $1.84 | $10.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.